HEADER TRANSCRIPTION 21-MAY-18 5ZXI TITLE CO-CRYSTAL STRUCTURE OF AN INHIBITOR IN COMPLEX WITH HUMAN PPARDELTA TITLE 2 LBD COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PPAR-DELTA,NUCI,NUCLEAR HORMONE RECEPTOR 1,NUC1,NUCLEAR COMPND 5 RECEPTOR SUBFAMILY 1 GROUP C MEMBER 2,PEROXISOME PROLIFERATOR- COMPND 6 ACTIVATED RECEPTOR BETA,PPAR-BETA; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PPARD, NR1C2, PPARB; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI K-12; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 83333 KEYWDS PPARDELTA, INHIBITOR COMPOUND CO-CRYSTAL STRUCTURE, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR S.T.RANI,A.LAXMINARASIMHAN,R.S.SENAIAR,N.KRISHNAMURTHY REVDAT 2 27-MAR-24 5ZXI 1 REMARK REVDAT 1 03-APR-19 5ZXI 0 JRNL AUTH B.LAGU,A.F.KLUGE,E.TOZZO,R.FREDENBURG,E.L.BELL, JRNL AUTH 2 M.M.GODDEERIS,P.DWYER,A.BASINSKI,R.S.SENAIAR,M.JALEEL, JRNL AUTH 3 N.K.TIWARI,S.K.PANIGRAHI,N.R.KRISHNAMURTHY,T.TAKAHASHI, JRNL AUTH 4 M.A.PATANE JRNL TITL SELECTIVE PPAR DELTA MODULATORS IMPROVE MITOCHONDRIAL JRNL TITL 2 FUNCTION: POTENTIAL TREATMENT FOR DUCHENNE MUSCULAR JRNL TITL 3 DYSTROPHY (DMD). JRNL REF ACS MED CHEM LETT V. 9 935 2018 JRNL REFN ISSN 1948-5875 JRNL PMID 30258544 JRNL DOI 10.1021/ACSMEDCHEMLETT.8B00287 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.7.0029 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.88 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 31926 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.220 REMARK 3 R VALUE (WORKING SET) : 0.217 REMARK 3 FREE R VALUE : 0.281 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1702 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.15 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2350 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.96 REMARK 3 BIN R VALUE (WORKING SET) : 0.2650 REMARK 3 BIN FREE R VALUE SET COUNT : 117 REMARK 3 BIN FREE R VALUE : 0.2990 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4018 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 66 REMARK 3 SOLVENT ATOMS : 151 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.34 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.07000 REMARK 3 B22 (A**2) : 0.03000 REMARK 3 B33 (A**2) : 0.04000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.01000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.246 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.219 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.167 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.223 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.936 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.900 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4172 ; 0.016 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 54 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5627 ; 1.884 ; 1.980 REMARK 3 BOND ANGLES OTHERS (DEGREES): 120 ; 0.817 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 490 ; 6.195 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 187 ;33.660 ;24.064 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 758 ;17.206 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 22 ;21.161 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 636 ; 0.119 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3070 ; 0.009 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 24 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN USED IF PRESENT IN REMARK 3 THE INPUT REMARK 4 REMARK 4 5ZXI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 29-MAY-18. REMARK 100 THE DEPOSITION ID IS D_1300007826. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-AUG-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31926 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 47.880 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 3.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.15 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: DIAMOND RODS REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.32 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 40MM BIS-TRIS-PROPANE (PH 8.0), 10% REMARK 280 (W/V) POLYETHYLENE GLYCOL (PEG) 8000, 200MM KCL, 6% PROPANOL, REMARK 280 1MM CACL2, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 38.32200 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 167 REMARK 465 SER A 168 REMARK 465 HIS A 169 REMARK 465 MET A 170 REMARK 465 LYS A 204 REMARK 465 ALA A 205 REMARK 465 SER A 206 REMARK 465 HIS A 207 REMARK 465 THR A 208 REMARK 465 ALA A 209 REMARK 465 LYS A 229 REMARK 465 GLN A 230 REMARK 465 LEU A 231 REMARK 465 VAL A 232 REMARK 465 ASN A 233 REMARK 465 GLY A 234 REMARK 465 LEU A 235 REMARK 465 PRO A 236 REMARK 465 PRO A 237 REMARK 465 ASP A 439 REMARK 465 MET A 440 REMARK 465 TYR A 441 REMARK 465 GLY B 167 REMARK 465 SER B 168 REMARK 465 HIS B 169 REMARK 465 MET B 170 REMARK 465 GLN B 171 REMARK 465 VAL B 172 REMARK 465 ALA B 173 REMARK 465 ASP B 174 REMARK 465 LEU B 175 REMARK 465 GLY B 203 REMARK 465 LYS B 204 REMARK 465 ALA B 205 REMARK 465 SER B 206 REMARK 465 HIS B 207 REMARK 465 THR B 208 REMARK 465 ALA B 209 REMARK 465 GLY B 225 REMARK 465 LEU B 226 REMARK 465 VAL B 227 REMARK 465 TRP B 228 REMARK 465 LYS B 229 REMARK 465 GLN B 230 REMARK 465 LEU B 231 REMARK 465 VAL B 232 REMARK 465 ASN B 233 REMARK 465 GLY B 234 REMARK 465 LEU B 235 REMARK 465 PRO B 236 REMARK 465 PRO B 237 REMARK 465 ASP B 439 REMARK 465 MET B 440 REMARK 465 TYR B 441 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NH1 ARG A 198 O HOH A 1001 1.93 REMARK 500 OE1 GLN B 408 O HOH B 1001 2.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 215 CB - CG - OD1 ANGL. DEV. = 7.0 DEGREES REMARK 500 GLY A 225 N - CA - C ANGL. DEV. = 18.0 DEGREES REMARK 500 PRO A 268 CB - CA - C ANGL. DEV. = 15.2 DEGREES REMARK 500 ARG A 419 NE - CZ - NH1 ANGL. DEV. = 3.6 DEGREES REMARK 500 ARG A 419 NE - CZ - NH2 ANGL. DEV. = -3.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 226 33.35 -140.15 REMARK 500 LYS A 239 -71.01 -137.28 REMARK 500 ASN A 366 79.08 -110.67 REMARK 500 TYR A 394 15.73 83.57 REMARK 500 LYS B 239 -54.83 -132.04 REMARK 500 SER B 269 -8.97 78.45 REMARK 500 ALA B 306 72.16 44.63 REMARK 500 ASN B 307 29.99 45.57 REMARK 500 ASN B 366 70.03 -101.07 REMARK 500 LYS B 422 -64.50 -99.49 REMARK 500 GLU B 424 70.80 -101.50 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1089 DISTANCE = 6.51 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 9LU A 900 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 9LU B 900 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5XMX RELATED DB: PDB DBREF 5ZXI A 171 441 UNP Q03181 PPARD_HUMAN 171 441 DBREF 5ZXI B 171 441 UNP Q03181 PPARD_HUMAN 171 441 SEQADV 5ZXI GLY A 167 UNP Q03181 EXPRESSION TAG SEQADV 5ZXI SER A 168 UNP Q03181 EXPRESSION TAG SEQADV 5ZXI HIS A 169 UNP Q03181 EXPRESSION TAG SEQADV 5ZXI MET A 170 UNP Q03181 EXPRESSION TAG SEQADV 5ZXI GLY B 167 UNP Q03181 EXPRESSION TAG SEQADV 5ZXI SER B 168 UNP Q03181 EXPRESSION TAG SEQADV 5ZXI HIS B 169 UNP Q03181 EXPRESSION TAG SEQADV 5ZXI MET B 170 UNP Q03181 EXPRESSION TAG SEQRES 1 A 275 GLY SER HIS MET GLN VAL ALA ASP LEU LYS ALA PHE SER SEQRES 2 A 275 LYS HIS ILE TYR ASN ALA TYR LEU LYS ASN PHE ASN MET SEQRES 3 A 275 THR LYS LYS LYS ALA ARG SER ILE LEU THR GLY LYS ALA SEQRES 4 A 275 SER HIS THR ALA PRO PHE VAL ILE HIS ASP ILE GLU THR SEQRES 5 A 275 LEU TRP GLN ALA GLU LYS GLY LEU VAL TRP LYS GLN LEU SEQRES 6 A 275 VAL ASN GLY LEU PRO PRO TYR LYS GLU ILE SER VAL HIS SEQRES 7 A 275 VAL PHE TYR ARG CYS GLN CYS THR THR VAL GLU THR VAL SEQRES 8 A 275 ARG GLU LEU THR GLU PHE ALA LYS SER ILE PRO SER PHE SEQRES 9 A 275 SER SER LEU PHE LEU ASN ASP GLN VAL THR LEU LEU LYS SEQRES 10 A 275 TYR GLY VAL HIS GLU ALA ILE PHE ALA MET LEU ALA SER SEQRES 11 A 275 ILE VAL ASN LYS ASP GLY LEU LEU VAL ALA ASN GLY SER SEQRES 12 A 275 GLY PHE VAL THR ARG GLU PHE LEU ARG SER LEU ARG LYS SEQRES 13 A 275 PRO PHE SER ASP ILE ILE GLU PRO LYS PHE GLU PHE ALA SEQRES 14 A 275 VAL LYS PHE ASN ALA LEU GLU LEU ASP ASP SER ASP LEU SEQRES 15 A 275 ALA LEU PHE ILE ALA ALA ILE ILE LEU CYS GLY ASP ARG SEQRES 16 A 275 PRO GLY LEU MET ASN VAL PRO ARG VAL GLU ALA ILE GLN SEQRES 17 A 275 ASP THR ILE LEU ARG ALA LEU GLU PHE HIS LEU GLN ALA SEQRES 18 A 275 ASN HIS PRO ASP ALA GLN TYR LEU PHE PRO LYS LEU LEU SEQRES 19 A 275 GLN LYS MET ALA ASP LEU ARG GLN LEU VAL THR GLU HIS SEQRES 20 A 275 ALA GLN MET MET GLN ARG ILE LYS LYS THR GLU THR GLU SEQRES 21 A 275 THR SER LEU HIS PRO LEU LEU GLN GLU ILE TYR LYS ASP SEQRES 22 A 275 MET TYR SEQRES 1 B 275 GLY SER HIS MET GLN VAL ALA ASP LEU LYS ALA PHE SER SEQRES 2 B 275 LYS HIS ILE TYR ASN ALA TYR LEU LYS ASN PHE ASN MET SEQRES 3 B 275 THR LYS LYS LYS ALA ARG SER ILE LEU THR GLY LYS ALA SEQRES 4 B 275 SER HIS THR ALA PRO PHE VAL ILE HIS ASP ILE GLU THR SEQRES 5 B 275 LEU TRP GLN ALA GLU LYS GLY LEU VAL TRP LYS GLN LEU SEQRES 6 B 275 VAL ASN GLY LEU PRO PRO TYR LYS GLU ILE SER VAL HIS SEQRES 7 B 275 VAL PHE TYR ARG CYS GLN CYS THR THR VAL GLU THR VAL SEQRES 8 B 275 ARG GLU LEU THR GLU PHE ALA LYS SER ILE PRO SER PHE SEQRES 9 B 275 SER SER LEU PHE LEU ASN ASP GLN VAL THR LEU LEU LYS SEQRES 10 B 275 TYR GLY VAL HIS GLU ALA ILE PHE ALA MET LEU ALA SER SEQRES 11 B 275 ILE VAL ASN LYS ASP GLY LEU LEU VAL ALA ASN GLY SER SEQRES 12 B 275 GLY PHE VAL THR ARG GLU PHE LEU ARG SER LEU ARG LYS SEQRES 13 B 275 PRO PHE SER ASP ILE ILE GLU PRO LYS PHE GLU PHE ALA SEQRES 14 B 275 VAL LYS PHE ASN ALA LEU GLU LEU ASP ASP SER ASP LEU SEQRES 15 B 275 ALA LEU PHE ILE ALA ALA ILE ILE LEU CYS GLY ASP ARG SEQRES 16 B 275 PRO GLY LEU MET ASN VAL PRO ARG VAL GLU ALA ILE GLN SEQRES 17 B 275 ASP THR ILE LEU ARG ALA LEU GLU PHE HIS LEU GLN ALA SEQRES 18 B 275 ASN HIS PRO ASP ALA GLN TYR LEU PHE PRO LYS LEU LEU SEQRES 19 B 275 GLN LYS MET ALA ASP LEU ARG GLN LEU VAL THR GLU HIS SEQRES 20 B 275 ALA GLN MET MET GLN ARG ILE LYS LYS THR GLU THR GLU SEQRES 21 B 275 THR SER LEU HIS PRO LEU LEU GLN GLU ILE TYR LYS ASP SEQRES 22 B 275 MET TYR HET 9LU A 900 33 HET 9LU B 900 33 HETNAM 9LU 6-[2-({2-[4-(FURAN-2-YL)PHENYL]-5-METHYL-1H-IMIDAZOL-1- HETNAM 2 9LU YL}METHYL)PHENOXY]HEXANOIC ACID FORMUL 3 9LU 2(C27 H28 N2 O4) FORMUL 5 HOH *151(H2 O) HELIX 1 AA1 GLN A 171 PHE A 190 1 20 HELIX 2 AA2 THR A 193 GLY A 203 1 11 HELIX 3 AA3 ASP A 215 LEU A 226 1 12 HELIX 4 AA4 GLU A 240 SER A 266 1 27 HELIX 5 AA5 SER A 269 LEU A 273 5 5 HELIX 6 AA6 PHE A 274 ALA A 295 1 22 HELIX 7 AA7 ARG A 314 SER A 319 1 6 HELIX 8 AA8 PRO A 323 ALA A 340 1 18 HELIX 9 AA9 ASP A 344 LEU A 357 1 14 HELIX 10 AB1 ASN A 366 HIS A 389 1 24 HELIX 11 AB2 TYR A 394 GLU A 424 1 31 HELIX 12 AB3 HIS A 430 LYS A 438 1 9 HELIX 13 AB4 ALA B 177 PHE B 190 1 14 HELIX 14 AB5 THR B 193 THR B 202 1 10 HELIX 15 AB6 ASP B 215 GLU B 223 1 9 HELIX 16 AB7 GLU B 240 LYS B 265 1 26 HELIX 17 AB8 SER B 269 LEU B 273 5 5 HELIX 18 AB9 PHE B 274 ALA B 295 1 22 HELIX 19 AC1 ALA B 306 GLY B 308 5 3 HELIX 20 AC2 ARG B 314 LEU B 320 1 7 HELIX 21 AC3 ILE B 328 LEU B 341 1 14 HELIX 22 AC4 ASP B 344 LEU B 357 1 14 HELIX 23 AC5 ASN B 366 HIS B 389 1 24 HELIX 24 AC6 TYR B 394 GLU B 424 1 31 HELIX 25 AC7 HIS B 430 LYS B 438 1 9 SHEET 1 AA1 4 PHE A 211 ILE A 213 0 SHEET 2 AA1 4 GLY A 310 THR A 313 1 O PHE A 311 N ILE A 213 SHEET 3 AA1 4 GLY A 302 VAL A 305 -1 N LEU A 303 O VAL A 312 SHEET 4 AA1 4 VAL A 298 ASN A 299 -1 N ASN A 299 O GLY A 302 SHEET 1 AA2 4 PHE B 211 ILE B 213 0 SHEET 2 AA2 4 GLY B 310 THR B 313 1 O THR B 313 N ILE B 213 SHEET 3 AA2 4 GLY B 302 VAL B 305 -1 N LEU B 303 O VAL B 312 SHEET 4 AA2 4 VAL B 298 ASN B 299 -1 N ASN B 299 O GLY B 302 CISPEP 1 LYS A 322 PRO A 323 0 -2.17 CISPEP 2 LYS B 322 PRO B 323 0 4.84 SITE 1 AC1 15 VAL A 245 CYS A 249 THR A 252 THR A 253 SITE 2 AC1 15 HIS A 287 LEU A 294 LEU A 303 VAL A 305 SITE 3 AC1 15 ILE A 328 LYS A 331 HIS A 413 MET A 417 SITE 4 AC1 15 LEU A 433 TYR A 437 HOH A1017 SITE 1 AC2 16 VAL B 245 PHE B 246 ARG B 248 CYS B 249 SITE 2 AC2 16 THR B 252 THR B 253 HIS B 287 LEU B 294 SITE 3 AC2 16 LEU B 303 ILE B 327 ILE B 328 LYS B 331 SITE 4 AC2 16 HIS B 413 LEU B 433 TYR B 437 HOH B1013 CRYST1 39.795 76.644 96.663 90.00 97.81 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025129 0.000000 0.003444 0.00000 SCALE2 0.000000 0.013047 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010442 0.00000